Armata Pharmaceuticals, Inc. — Director's Dealing 2020

Mar 31, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2020-03-27

Reporting Person: Innoviva, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-27	Common Stock	P	7717661	$2.87	Acquired	8710800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-27	Warrants to Acquire Common Stock	$2.87	P	7717661	Acquired	2025-03-27	Common Stock (7717661)	Direct

Footnotes

F1: See Exhibit 99.1.